Skip to main content
. 2022 Jun 8;12:759864. doi: 10.3389/fonc.2022.759864

Figure 7.

Figure 7

STK25 overexpression inhibits the expression of tumor stem cell markers and EMT in HCC cells promoted by miR-4800-3p through the Hippo pathway. (A) The stemness of HepB3 and LM3 cells was evaluated using a sphere formation assay. qPCR and Western blot analysis of tumor stem cell markers (CD44, CD133, and OCT4) (B, C) and EMT biomarkers (E-cadherin, ZO-1, and N-cadherin) (D, E) in HepB3 and LM3 cells. (F) Western blot was used to detect the expression of p-YAP, YAP, TAZ, and PCNA in HepB3 and LM3 cells. *p < 0.05 and **p < 0.01 vs. mimic+OE-NC.